Implantation or Injectable Dosage Form New Animal Drugs; Enrofloxacin Solution
other · Food and Drug Administration · Rule · Published 1997-07-21 · 62 FR 38907
Document
Document number
97-19126
Federal Register citation
62 FR 38907
CFR reference
21 CFR 522
Type
Rule
Action
Final rule.
Category
other
Sub-agency
Food and Drug Administration
Publication date
1997-07-21
Abstract
The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of a supplemental new animal drug application (NADA) filed by Bayer Corp., Agriculture Div., Animal Health. The supplemental NADA provides for revised indications for use of enrofloxacin injectable solution in dogs for the management of diseases associated with bacteria susceptible to enrofloxacin.